Promising combo therapy may help vitiligo patients regain skin pigment
NCT ID NCT03036995
First seen Apr 02, 2026 · Last updated May 17, 2026 · Updated 10 times
Summary
This study tested whether a drug called apremilast, combined with UVB light therapy, can help restore skin color in people with vitiligo. Eighty adults with vitiligo covering at least 10% of their body took part. The goal was to see if the combination works better than light therapy alone for repigmentation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice - Dermatologie - Hôpital Archet
Nice, Alpes-Maritimes, 06, France
Conditions
Explore the condition pages connected to this study.